142 related articles for article (PubMed ID: 9387887)
1. D1 receptors mediate dopamine action in the fetal suprachiasmatic nuclei: studies of mice with targeted deletion of the D1 dopamine receptor gene.
Bender M; Drago J; Rivkees SA
Brain Res Mol Brain Res; 1997 Oct; 49(1-2):271-7. PubMed ID: 9387887
[TBL] [Abstract][Full Text] [Related]
2. D1-dopamine receptors activate c-fos expression in the fetal suprachiasmatic nuclei.
Weaver DR; Rivkees SA; Reppert SM
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9201-4. PubMed ID: 1384044
[TBL] [Abstract][Full Text] [Related]
3. Definition of the developmental transition from dopaminergic to photic regulation of c-fos gene expression in the rat suprachiasmatic nucleus.
Weaver DR; Reppert SM
Brain Res Mol Brain Res; 1995 Oct; 33(1):136-48. PubMed ID: 8774955
[TBL] [Abstract][Full Text] [Related]
4. c-fos and jun-B mRNAs are transiently expressed in fetal rodent suprachiasmatic nucleus following dopaminergic stimulation.
Weaver DR; Roca AL; Reppert SM
Brain Res Dev Brain Res; 1995 Apr; 85(2):293-7. PubMed ID: 7600678
[TBL] [Abstract][Full Text] [Related]
5. Prenatal exposure to the dopamine agonist SKF-38393 disrupts the timing of the initial response of the suprachiasmatic nucleus to light.
Ferguson SA; Rowe SA; Krupa M; Kennaway DJ
Brain Res; 2000 Mar; 858(2):284-9. PubMed ID: 10708679
[TBL] [Abstract][Full Text] [Related]
6. Anatomical and functional characterisation of a dopaminergic system in the suprachiasmatic nucleus of the neonatal Siberian hamster.
Duffield GE; McNulty S; Ebling FJ
J Comp Neurol; 1999 May; 408(1):73-96. PubMed ID: 10331581
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of adenosine A1 receptors attenuates dopamine D1 receptor-mediated increase of NGFI-A, c-fos and jun-B mRNA levels in the dopamine-denervated striatum and dopamine D1 receptor-mediated turning behaviour.
Ferré S; Rimondini R; Popoli P; Reggio R; Pèzzola A; Hansson AC; Andersson A; Fuxe K
Eur J Neurosci; 1999 Nov; 11(11):3884-92. PubMed ID: 10583477
[TBL] [Abstract][Full Text] [Related]
8. Alteration by maternal pinealectomy of fetal and neonatal melatonin and dopamine D1 receptor binding in the suprachiasmatic nuclei.
Naitoh N; Watanabe Y; Matsumura K; Murai I; Kobayashi K; Imai-Matsumura K; Ohtuka H; Takagi K; Miyake Y; Satoh K; Watanabe Y
Biochem Biophys Res Commun; 1998 Dec; 253(3):850-4. PubMed ID: 9918818
[TBL] [Abstract][Full Text] [Related]
9. Regulation of human D1 dopamine receptor function and gene expression in SK-N-MC neuroblastoma cells.
Sidhu A; Olde B; Humblot N; Kimura K; Gardner N
Neuroscience; 1999; 91(2):537-47. PubMed ID: 10366011
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D1-like receptors agonist SKF 38393 increases cFOS expression in the paraventricular nucleus of the hypothalamus--impact of acute and chronic cocaine.
Chocyk A; Czyrak A; Wedzony K
J Physiol Pharmacol; 2008 Sep; 59(3):425-40. PubMed ID: 18953088
[TBL] [Abstract][Full Text] [Related]
11. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
Wirtshafter D; Osborn CV
Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
[TBL] [Abstract][Full Text] [Related]
12. Entrainment of the fetal hamster circadian pacemaker by prenatal injections of the dopamine agonist SKF 38393.
Viswanathan N; Weaver DR; Reppert SM; Davis FC
J Neurosci; 1994 Sep; 14(9):5393-8. PubMed ID: 7916044
[TBL] [Abstract][Full Text] [Related]
13. Blockade of neurotensin receptors suppresses the dopamine D1/D2 synergism on immediate early gene expression in the rat brain.
Alonso R; Gnanadicom H; Fréchin N; Fournier M; Le Fur G; Soubrié P
Eur J Neurosci; 1999 Mar; 11(3):967-74. PubMed ID: 10103090
[TBL] [Abstract][Full Text] [Related]
14. D1 dopamine receptor agonist (SKF-38393) induction of Fos immunoreactivity in progestin receptor-containing areas of female rat brain.
Meredith JM; Auger AP; Blaustein JD
J Neuroendocrinol; 1997 May; 9(5):385-94. PubMed ID: 9181492
[TBL] [Abstract][Full Text] [Related]
15. Widespread expression of functional D1-dopamine receptors in fetal rat brain.
Shearman LP; Zeitzer J; Weaver DR
Brain Res Dev Brain Res; 1997 Aug; 102(1):105-15. PubMed ID: 9298239
[TBL] [Abstract][Full Text] [Related]
16. Distinct pharmacological mechanisms leading to c-fos gene expression in the fetal suprachiasmatic nucleus.
Shearman LP; Weaver DR
J Biol Rhythms; 2001 Dec; 16(6):531-40. PubMed ID: 11760011
[TBL] [Abstract][Full Text] [Related]
17. G(olf)alpha mediates dopamine D1 receptor signaling.
Zhuang X; Belluscio L; Hen R
J Neurosci; 2000 Aug; 20(16):RC91. PubMed ID: 10924528
[TBL] [Abstract][Full Text] [Related]
18. Functional D1 and D5 dopamine receptors are expressed in the suprachiasmatic, supraoptic, and paraventricular nuclei of primates.
Rivkees SA; Lachowicz JE
Synapse; 1997 May; 26(1):1-10. PubMed ID: 9097400
[TBL] [Abstract][Full Text] [Related]
19. D1-dopamine receptor binding and tyrosine hydroxylase-immunoreactivity in the fetal and neonatal hamster suprachiasmatic nucleus.
Strother WN; Norman AB; Lehman MN
Brain Res Dev Brain Res; 1998 Mar; 106(1-2):137-44. PubMed ID: 9554985
[TBL] [Abstract][Full Text] [Related]
20. Influence of glucocorticoids on dopaminergic transmission in the rat dorsolateral striatum.
Barrot M; Abrous DN; Marinelli M; Rougé-Pont F; Le Moal M; Piazza PV
Eur J Neurosci; 2001 Feb; 13(4):812-8. PubMed ID: 11207816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
